Neuroendocrine Tumors: The Slow Cancer With Hormone Symptoms

Last updated September 4, 2026.

A neuroendocrine tumor, NET, is a cancer that grows from hormone-producing cells found throughout the body, most often in the gut, the pancreas, or the lungs. These tumors confound the usual cancer expectations: many grow slowly over years, some announce themselves through hormone effects rather than lumps, and a diagnosis that sounds terrifying often turns into a condition people live with, and treat, for a long time.

The hormone signature

Because the cells make hormones, some NETs produce symptoms from the hormones themselves. The classic picture, called carcinoid syndrome, is episodes of facial flushing and watery diarrhea, sometimes with wheezing or a racing heart, usually from a gut tumor that has reached the liver. Other tumors overproduce insulin, stomach acid, or other hormones, each with its own symptom pattern. Many NETs make no hormones at all and are found by chance on a scan done for something else.

A stage 4 low-grade NET is not the usual stage 4 story: these tumors grow slowly and are managed for years. Grade beats stage, the blood marker tracks it, and keeping the follow-up is the whole job.

Start a free AI doctor consult →

How it is found and staged

Diagnosis combines scans, blood and urine tests for hormone byproducts such as chromogranin A and 5-HIAA, and a biopsy that grades how fast the cells are dividing. That grade matters more than almost anything: low-grade tumors can idle for a decade, while high-grade ones behave aggressively and are treated like other fast cancers. Specialized scans that light up the tumor's receptors map where it is and, usefully, predict which treatments will stick to it.

How it is treated

Surgery removes what can be removed, and even when a NET has spread, removing bulk can control symptoms for years. Hormone-blocking injections, the somatostatin analogs octreotide and lanreotide, control flushing and diarrhea and slow tumor growth in many people. Beyond those sit targeted pills, a receptor-targeted radiation treatment given through a vein called PRRT, chemotherapy for the faster grades, and liver-directed procedures when the disease concentrates there. Newly diagnosed people commonly cycle through several of these over the years, which is why NET care runs through specialist centers. The realistic frame for most low-grade NETs is chronic disease management: long stretches of ordinary life punctuated by scans and treatment decisions.

Slow does not mean ignore. A low-grade NET earns years of life partly because the follow-up is kept. Scans and blood markers are the steering wheel; keep the appointments.
Track the hormone symptoms. Flushing and diarrhea episodes, their triggers, and their frequency are treatment information. A simple diary makes the injections work harder.
Ask about the tumor's receptors. Whether your tumor lights up on the receptor scan decides whether the targeted radiation treatment is an option for you. It is one of the most useful questions you can ask.

If you are weighing the risks and benefits of any medicine mentioned here, our overview of how medicines are tested and monitored for safety explains what those conversations are built on.

What a Pymander AI doctor consult looks like

I am 52 and a scan for belly pain found a small bowel neuroendocrine tumor with spots on my liver. The oncologist keeps calling it slow-growing and talking about managing it for years, but it is stage 4 and I do not understand how anyone is calm about this. Am I being managed or am I being written off?

You are being managed, and the calm is earned, not casual. Here is the thing that takes time to absorb: stage 4 means something different in this disease. In most cancers it signals the endgame; in low-grade NETs it describes a tumor that spreads early but grows slowly, and people live with it, on treatment, for many years, often a decade and more. Your oncologist's language is not soft-pedaling; it is the accurate description of the biology. The plan for a case like yours is well trodden: hormone-blocking injections to control growth and symptoms, consideration of surgery or liver-directed treatment for the bulk, the receptor scan to see if targeted radiation is an option, and a marker in your blood to track it. You will likely cycle through treatments over the years rather than use everything at once, because the disease gives time and the strategy is to spend the options slowly. The written-off feeling is worth naming to your team, because the one real hazard in slow diseases is drifting out of follow-up. Stay in the room, keep the scans, and let the years accumulate.

Thanks for giving me all this information. A stage 4 label on a slow cancer is a confusing thing to hold, and your suspicion of the calm is understandable. The answer to hold onto is that the biology of your tumor, not the stage number, is what writes the prognosis, and low-grade NET biology is the most forgiving in the cancer world. Your questions for the oncologist: what is my tumor's grade, does it light up on the receptor scan, what marker are we tracking, and what is the sequence of options you have in mind for me. You are not being written off. You are being managed by people who expect to be treating you for a long time.

Care note

New-diagnosis consult, 52M stage 4 low-grade small-bowel NET. The core confusion is stage-number dread vs indolent biology, and the consult names it directly rather than dancing around it. 'Spend the options slowly' captures the sequencing strategy. Follow-up-drift named as the real hazard of indolent disease.

No survival figures quoted (NET outcomes vary hugely by grade and site; the honest unit for low grade is years to a decade and more). Grade-over-stage emphasized as the page's central idea. Sources: Cleveland 22006, MedlinePlus 000393 (renders 'Pancreatic neuroendocrine tumors' - organ-specific page, flagged; Cleveland page is the general one). No chains, banned adverbs absent.

View care note →

Illustrative example, not a real member's messages.

Common questions

Is a neuroendocrine tumor cancer?

Yes, but an unusual one. Low-grade NETs grow slowly and are managed as a chronic condition for years, while high-grade ones behave aggressively. The grade from your biopsy, more than the stage, tells you which disease you have.

What is carcinoid syndrome?

Episodes of facial flushing and watery diarrhea, sometimes with wheezing or palpitations, caused by hormones the tumor releases, usually when a gut NET has reached the liver. Hormone-blocking injections control it well in most people.

Why is my oncologist not rushing to treat stage 4?

Because in low-grade NETs, stage 4 describes spread, not speed. These tumors can idle for years, and treatments are sequenced over time to control growth and symptoms. Starting everything at once gains nothing and spends options early.

What is PRRT and can I have it?

It is a targeted radiation treatment carried by a molecule that sticks to the tumor's receptors, given through a vein. Whether your tumor has those receptors is shown by a specialized scan, so that scan result decides it. It is one of the most useful questions to ask your team.

What blood tests track this?

Chromogranin A is the commonest blood marker, and 5-HIAA in urine or blood tracks the hormone behind carcinoid syndrome. Your team picks the markers that match your tumor, and the trend matters more than any single value.

Does this run in families?

Almost always not. A small minority of NETs come with inherited syndromes, and your team will say if your pattern suggests one. Most people can tell their relatives that no screening is needed.

Sources

Pymander is not a replacement for a physician and does not provide medical advice, diagnosis, or treatment.